Linfeng Mao

机构：Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, Tumor Hospital of Guangxi Medical University · ORCID：0000-0001-8113-1253

发表论文 29 篇 · 总被引 950 次 · h-index 13

代表论文

• Emerging Nanoclay Composite for Effective Hemostasis (2017 · Advanced Functional Materials · 被引 198)
• Intercalated 2D nanoclay for emerging drug delivery in cancer therapy (2017 · Nano Research · 被引 136)
• EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis (2021 · Oncogene · 被引 88)
• EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance (2019 · International Journal of Cancer · 被引 85)
• Buoyant Metal–Organic Framework Corona-Driven Fast Isolation and Ultrasensitive Profiling of Circulating Extracellular Vesicles (2024 · ACS Nano · 被引 65)
• Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer (2018 · Thyroid · 被引 49)